Literature DB >> 10766903

Frataxin point mutations in two patients with Friedreich's ataxia and unusual clinical features.

M L McCormack1, R P Guttmann, M Schumann, J M Farmer, C A Stolle, V Campuzano, M Koenig, D R Lynch.   

Abstract

Two patients with a progressive ataxia are presented with clinical features consistent with classic Friedreich's ataxia (FRDA), but also with features unusual for FRDA. Analysis of DNA showed that each patient is heterozygous for the expanded GAA repeat of FRDA, but carries a base change on his other frataxin allele. For one patient a non-conservative arginine to cysteine amino acid change is predicted at amino acid 165 whereas the other mutation is found at the junction of exon one and intron one. Muscle biopsy showed an absence of frataxin immunoreactivity in the patient harbouring the intronic mutation, confirming the pathological nature of the base change. These mutations extend the range of point mutations seen in FRDA, and agree with recent reports suggesting phenotypic variation in patients with FRDA harbouring point mutations in conjunction with an expanded GAA repeat.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10766903      PMCID: PMC1736939          DOI: 10.1136/jnnp.68.5.661

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

Review 1.  Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.

Authors:  Renata Santos; Sophie Lefevre; Dominika Sliwa; Alexandra Seguin; Jean-Michel Camadro; Emmanuel Lesuisse
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

2.  Predicting changes in protein stability caused by mutation using sequence-and structure-based methods in a CAGI5 blind challenge.

Authors:  Alexey Strokach; Carles Corbi-Verge; Philip M Kim
Journal:  Hum Mutat       Date:  2019-08-07       Impact factor: 4.878

Review 3.  Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders.

Authors:  Sweta Shah; Marc Marie Dooms; Sofia Amaral-Garcia; Mariana Igoillo-Esteve
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

4.  Analysis of the visual system in Friedreich ataxia.

Authors:  Lauren A Seyer; Kristin Galetta; James Wilson; Reiko Sakai; Susan Perlman; Katherine Mathews; George R Wilmot; Christopher M Gomez; Bernard Ravina; Theresa Zesiewicz; Khalaf O Bushara; S H Subramony; Tetsuo Ashizawa; Martin B Delatycki; Alicia Brocht; Laura J Balcer; David R Lynch
Journal:  J Neurol       Date:  2013-06-18       Impact factor: 4.849

Review 5.  Pharmacotherapy for Friedreich ataxia.

Authors:  Amy Y Tsou; Lisa S Friedman; Robert B Wilson; David R Lynch
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 6.  Unanswered questions in Friedreich ataxia.

Authors:  David R Lynch; Eric C Deutsch; Robert B Wilson; Gihan Tennekoon
Journal:  J Child Neurol       Date:  2012-07-25       Impact factor: 1.987

7.  Frataxin gene point mutations in Italian Friedreich ataxia patients.

Authors:  Cinzia Gellera; Barbara Castellotti; Caterina Mariotti; Rossana Mineri; Viviana Seveso; Stefano Didonato; Franco Taroni
Journal:  Neurogenetics       Date:  2007-08-17       Impact factor: 2.660

8.  The first biallelic missense mutation in the FXN gene in a consanguineous Turkish family with Charcot-Marie-Tooth-like phenotype.

Authors:  Ayşe Candayan; Gulshan Yunisova; Arman Çakar; Hacer Durmuş; A Nazlı Başak; Yeşim Parman; Esra Battaloğlu
Journal:  Neurogenetics       Date:  2019-10-31       Impact factor: 2.660

9.  Clinical use of frataxin measurement in a patient with a novel deletion in the FXN gene.

Authors:  Francesco Saccà; Angela Marsili; Giorgia Puorro; Antonella Antenora; Chiara Pane; Alessandra Tessa; Pasquale Scoppettuolo; Claudia Nesti; Vincenzo Brescia Morra; Giuseppe De Michele; Filippo M Santorelli; Alessandro Filla
Journal:  J Neurol       Date:  2012-11-30       Impact factor: 4.849

10.  Frataxin levels in peripheral tissue in Friedreich ataxia.

Authors:  Michael Lazaropoulos; Yina Dong; Elisia Clark; Nathaniel R Greeley; Lauren A Seyer; Karlla W Brigatti; Carlton Christie; Susan L Perlman; George R Wilmot; Christoper M Gomez; Katherine D Mathews; Grace Yoon; Theresa Zesiewicz; Chad Hoyle; Sub H Subramony; Alicia F Brocht; Jennifer M Farmer; Robert B Wilson; Eric C Deutsch; David R Lynch
Journal:  Ann Clin Transl Neurol       Date:  2015-07-01       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.